In the BioHarmony Drug Report Database
Morphine
Arymo Er, Avinza, Depodur, Duramorph Pf, Infumorph, Kadian, Morphabond Er, Morphine Sulfate, Ms Contin, Oramorph Sr (morphine) is a small molecule pharmaceutical. Morphine was first approved as Arymo Er on 1984-09-18. It is used to treat dyspnea and intractable pain in the USA. The pharmaceutical is active against mu-type opioid receptor. In addition, it is known to target delta-type opioid receptor, kappa-type opioid receptor, and Ig lambda-1 chain V regions MOPC 104E/RPC20/J558/S104. Infumorph 200’s patents are valid until 2034-03-12 (FDA).
Trade Name
|
Arymo Er, Avinza, Depodur, Duramorph Pf, Infumorph, Kadian, Morphabond Er, Morphine Sulfate, Ms Contin, Oramorph Sr |
|---|---|
Common Name
|
morphine |
ChEMBL ID
|
CHEMBL70 |
Indication
|
dyspnea, intractable pain |
Drug Class
|
Opioid |
Image (chem structure or protein)